These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1713394)

  • 1. Modified tau is present in younger nondemented persons: a study of subcortical nuclei in Alzheimer's disease and progressive supranuclear palsy.
    Shin RW; Kitamoto T; Tateishi J
    Acta Neuropathol; 1991; 81(5):517-23. PubMed ID: 1713394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease.
    Probst A; Langui D; Lautenschlager C; Ulrich J; Brion JP; Anderton BH
    Acta Neuropathol; 1988; 77(1):61-8. PubMed ID: 3149122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging.
    Hauw JJ; Verny M; Delaère P; Cervera P; He Y; Duyckaerts C
    Neurosci Lett; 1990 Nov; 119(2):182-6. PubMed ID: 1704110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
    Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease.
    Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N
    J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles.
    Cruz-Sanchez FF; Rossi ML; Cardozo A; Deacon P; Tolosa E
    Neurosci Lett; 1992 Feb; 136(1):43-6. PubMed ID: 1321966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
    Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
    Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy.
    Dugger BN; Tu M; Murray ME; Dickson DW
    Neurosci Lett; 2011 Mar; 491(2):122-6. PubMed ID: 21236314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease.
    Schmidt ML; Lee VM; Hurtig H; Trojanowski JQ
    Lab Invest; 1988 Oct; 59(4):460-6. PubMed ID: 2459498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
    Flament S; Delacourte A; Verny M; Hauw JJ; Javoy-Agid F
    Acta Neuropathol; 1991; 81(6):591-6. PubMed ID: 1831952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX.
    Uchihara T; Endo K; Kondo H; Okabayashi S; Shimozawa N; Yasutomi Y; Adachi E; Kimura N
    Acta Neuropathol Commun; 2016 Nov; 4(1):118. PubMed ID: 27842611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.
    Bancher C; Lassmann H; Budka H; Grundke-Iqbal I; Iqbal K; Wiche G; Seitelberger F; Wisniewski HM
    Acta Neuropathol; 1987; 74(1):39-46. PubMed ID: 2444063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies.
    Uchihara T; Hara M; Nakamura A; Hirokawa K
    Histochem Cell Biol; 2012 Feb; 137(2):261-7. PubMed ID: 22116524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive supranuclear palsy with dementia: cortical pathology.
    Bigio EH; Brown DF; White CL
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):359-64. PubMed ID: 10218631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.
    Ebashi M; Ito Y; Uematsu M; Nakamura A; Hirokawa K; Kamei S; Uchihara T
    Acta Neuropathol Commun; 2019 May; 7(1):71. PubMed ID: 31060611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
    Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
    Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy.
    Mori H; Nishimura M; Namba Y; Oda M
    Acta Neuropathol; 1994; 88(2):113-21. PubMed ID: 7985491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.